Abstract
Ten patients had serial evaluations of plasma prostaglandin E2, prostaglandin 2α, and 6-keto-PG1α during administration of cis-platinum chemotherapy. No significant changes were noted in PGF2α and 6-keto-PGF1α whereas PGE2 showed a decrease. This would indicate that the nausea and vomiting of platinum therapy is not a result of tumor release of prostaglandins. All patients had known residual cancer and all had elevated levels of PGE2 and 6-keto-PGF1α.
Original language | English (US) |
---|---|
Pages (from-to) | 89-91 |
Number of pages | 3 |
Journal | Gynecologic Oncology |
Volume | 12 |
Issue number | 1 |
DOIs | |
State | Published - Aug 1981 |
All Science Journal Classification (ASJC) codes
- Oncology
- Obstetrics and Gynecology